Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/32150
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-04-03T11:54:54Z | - |
dc.date.available | 2023-04-03T11:54:54Z | - |
dc.date.issued | 2004-08 | - |
dc.identifier.citation | Ali, R. vd. (2004). “Primary non-Hodgkin's T-cell lymphoma of bone”. Leukemia and Lymphoma, 45(8), 1719-1720. | en_US |
dc.identifier.issn | 1042-8194 | - |
dc.identifier.uri | https://doi.org/10.1080/10428190410001683778 | - |
dc.identifier.uri | https://www.tandfonline.com/doi/abs/10.1080/10428190410001683778 | - |
dc.identifier.uri | http://hdl.handle.net/11452/32150 | - |
dc.language.iso | en | en_US |
dc.publisher | Taylor and Francis | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject | Hematology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Bone neoplasms | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lymphoma, T-cell | en_US |
dc.subject.mesh | Male | en_US |
dc.title | Primary non-Hodgkin's T-cell lymphoma of bone | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000221862800036 | tr_TR |
dc.identifier.scopus | 2-s2.0-3042772795 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 1719 | tr_TR |
dc.identifier.endpage | 1720 | tr_TR |
dc.identifier.volume | 45 | tr_TR |
dc.identifier.issue | 8 | tr_TR |
dc.relation.journal | Leukemia and Lymphoma | en_US |
dc.contributor.buuauthor | Ali, Rıdvan | - |
dc.contributor.buuauthor | Özkalemkaş, Fahir | - |
dc.contributor.buuauthor | Özçelik, Tülay | - |
dc.contributor.buuauthor | Ozan, Ülkü | - |
dc.contributor.buuauthor | Özkocaman, Vildan | - |
dc.contributor.buuauthor | Tunalı, Ahmet | - |
dc.contributor.researcherid | AAG-8495-2021 | tr_TR |
dc.contributor.researcherid | AAH-1854-2021 | tr_TR |
dc.identifier.pubmed | 15370235 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Hematology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 (Hematology) | en_US |
dc.wos.quartile | Q4 (Oncology) | en_US |
dc.contributor.scopusid | 7201813027 | tr_TR |
dc.contributor.scopusid | 6601912387 | tr_TR |
dc.contributor.scopusid | 7005424333 | tr_TR |
dc.contributor.scopusid | 6507254632 | tr_TR |
dc.contributor.scopusid | 6603145040 | tr_TR |
dc.contributor.scopusid | 6602797853 | tr_TR |
dc.subject.emtree | Abdominal pain | en_US |
dc.subject.emtree | Abdominal surgery | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Bone cancer | en_US |
dc.subject.emtree | Bone pain | en_US |
dc.subject.emtree | Bone scintiscanning | en_US |
dc.subject.emtree | Cancer radiotherapy | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Computer assisted tomography | en_US |
dc.subject.emtree | Death | en_US |
dc.subject.emtree | Hip radiography | en_US |
dc.subject.emtree | Histopathology | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nonhodgkin lymphoma | en_US |
dc.subject.emtree | Nuclear magnetic resonance imaging | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | T cell lymphoma | en_US |
dc.subject.emtree | Treatment failure | en_US |
dc.subject.emtree | Tumor volume | en_US |
dc.subject.emtree | Cisplatin | en_US |
dc.subject.emtree | Cyclophosphamide | en_US |
dc.subject.emtree | Cytarabine | en_US |
dc.subject.emtree | Doxorubicin | en_US |
dc.subject.emtree | Etoposide | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Prednisone | en_US |
dc.subject.emtree | Vincristine | en_US |
Appears in Collections: | Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.